Editas Medicine (EDIT) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to -$165.6 million.
- Editas Medicine's Enterprise Value rose 3751.21% to -$165.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$165.6 million, marking a year-over-year increase of 3751.21%. This contributed to the annual value of -$269.9 million for FY2024, which is 1646.43% up from last year.
- Editas Medicine's Enterprise Value amounted to -$165.6 million in Q3 2025, which was up 3751.21% from -$178.5 million recorded in Q2 2025.
- Over the past 5 years, Editas Medicine's Enterprise Value peaked at -$165.6 million during Q3 2025, and registered a low of -$625.3 million during Q1 2021.
- For the 5-year period, Editas Medicine's Enterprise Value averaged around -$373.5 million, with its median value being -$344.3 million (2022).
- In the last 5 years, Editas Medicine's Enterprise Value crashed by 5068.52% in 2021 and then soared by 3751.21% in 2025.
- Over the past 5 years, Editas Medicine's Enterprise Value (Quarter) stood at -$499.8 million in 2021, then skyrocketed by 31.12% to -$344.3 million in 2022, then rose by 6.15% to -$323.1 million in 2023, then grew by 16.46% to -$269.9 million in 2024, then skyrocketed by 38.63% to -$165.6 million in 2025.
- Its Enterprise Value stands at -$165.6 million for Q3 2025, versus -$178.5 million for Q2 2025 and -$221.0 million for Q1 2025.